Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1908161

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1908161

Middle East Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services, By Source, By Type of Cell Line, By Source, By Application, By Country, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Middle East Cell Line Development Market Summary

The Middle East cell line development market size was valued at USD 164.9 million in 2024 and is projected to grow to USD 340.9 million by 2033, registering a CAGR of 8.38% between 2025 and 2033. The growth is driven by increasing investments in biopharmaceutical research, expanding contract development and manufacturing services, and rising demand for novel therapeutics and personalized medicine in the region.

Advancements in Bioprocessing Technologies

Rapid advances in bioprocessing technologies are driving the Middle East cell line development market. Automated cell culture, high-throughput screening, and 3D cell culture techniques are increasingly used by research institutions, biotech firms, and pharmaceutical companies, enabling faster, more consistent, and reproducible cell line development. This accelerates the creation of monoclonal antibodies, recombinant proteins, and other biologics to meet growing demand for innovative therapeutics.

Middle East Cell Line Development Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the Middle East cell line development market on the basis of product & services, source, type of cell lines, application, and country:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagents and media
  • Equipment
    • Automated Systems
    • Centrifuges
    • Bioreactors
    • Storage equipment
    • Others
  • Accessories and consumables
  • Services
  • Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammalian cell line
  • Non-mammalian cell line
    • Insects
    • Amphibians
  • Type of Cell Lines Outlook (Revenue, USD Million, 2021 - 2033)
  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Bioproduction
  • Drug discovery
  • Toxicity testing
  • Tissue engineering & Regenerative Medicine
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar
    • Rest of Middle East
Product Code: GVR-4-68040-833-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product & Services
    • 1.1.2. Source
    • 1.1.3. Type of Cell Lines
    • 1.1.4. Application
  • 1.2. Market Definitions
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Others
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Advancements in Bioprocessing Technologies
      • 3.3.1.2. Increasing Clinical Trials and Drug Development
  • 3.4. Market Restraint Analysis
      • 3.4.1.1. Presence of complicated regulatory framework
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Middle East Cell Line Development Market: Product & Services Movement Analysis
  • 4.3. Middle East Cell Line Development Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
  • 4.4. Reagents and Media
    • 4.4.1. Reagents and Media Market, 2021 - 2033 (USD Million)
  • 4.5. Equipment
    • 4.5.1. Equipment Market, 2021 - 2033 (USD Million)
    • 4.5.2. Automated Systems
      • 4.5.2.1. Automated Systems Market, 2021 - 2033 (USD Million)
    • 4.5.3. Centrifuges
      • 4.5.3.1. Centrifuges Market, 2021 - 2033 (USD Million)
    • 4.5.4. Bioreactors
      • 4.5.4.1. Bioreactors Market, 2021 - 2033 (USD Million)
    • 4.5.5. Storage Equipment
      • 4.5.5.1. Storage Equipment Market, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2021 - 2033 (USD Million)
  • 4.6. Accessories and Consumables
    • 4.6.1. Accessories and Consumables Market, 2021 - 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Source Business Analysis

  • 5.1. Source Segment Dashboard
  • 5.2. Middle East Cell Line Development Market: Source Movement Analysis
  • 5.3. Middle East Cell Line Development Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
  • 5.4. Mammalian Cell Line
    • 5.4.1. Mammalian Cell Line Market, 2021 - 2033 (USD Million)
  • 5.5. Non-Mammalian Cell Line
    • 5.5.1. Non-Mammalian Cell Line Market, 2021 - 2033 (USD Million)
    • 5.5.2. Insects
      • 5.5.2.1. Insects Market, 2021 - 2033 (USD Million)
    • 5.5.3. Amphibians
      • 5.5.3.1. Amphibians Market, 2021 - 2033 (USD Million)

Chapter 6. Type of Cell Lines Business Analysis

  • 6.1. Type of Cell Lines Segment Dashboard
  • 6.2. Middle East Cell Line Development Market: Type of Cell Lines Movement Analysis
  • 6.3. Middle East Cell Line Development Market Size & Trend Analysis, by Type of Cell Lines, 2021 to 2033 (USD Million)
  • 6.4. Recombinant Cell Lines
    • 6.4.1. Recombinant Cell Lines Market, 2021 - 2033 (USD Million)
  • 6.5. Hybridomas
    • 6.5.1. Hybridomas Market, 2021 - 2033 (USD Million)
  • 6.6. Continuous Cell Lines
    • 6.6.1. Continuous Cell Lines Market, 2021 - 2033 (USD Million)
  • 6.7. Primary Cell Lines
    • 6.7.1. Primary Cell Lines Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Middle East Cell Line Development market: Application Movement Analysis
  • 7.3. Middle East Cell Line Development Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Bioproduction
    • 7.4.1. Bioproduction Market, 2021 - 2033 (USD Million)
  • 7.5. Drug Discovery
    • 7.5.1. Drug Discovery Market, 2021 - 2033 (USD Million)
  • 7.6. Toxicity Testing
    • 7.6.1. Toxicity Testing Market, 2021 - 2033 (USD Million)
  • 7.7. Tissue Engineering & Regenerative Medicine
    • 7.7.1. Tissue Engineering & Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Country Business Analysis

  • 8.1. Middle East Cell Line Development Market Share By Country, 2024 & 2033
  • 8.2. Middle East
    • 8.2.1. MEA Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
    • 8.2.2. Saudi Arabia
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Saudi Arabia Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
    • 8.2.3. UAE
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. UAE Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
    • 8.2.4. Kuwait
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Kuwait Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
    • 8.2.5. Oman
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Competitive Scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Oman Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
    • 8.2.6. Qatar
      • 8.2.6.1. Key Country Dynamics
      • 8.2.6.2. Competitive Scenario
      • 8.2.6.3. Regulatory Framework
      • 8.2.6.4. Qatar Middle East Cell Line Development Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Merck KGaA
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Sartorius AG
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Lonza
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. WuXi PharmaTech
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Advanced Instruments
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Berkeley Lights
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Creative BioLabs
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Corning Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
Product Code: GVR-4-68040-833-3

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Middle East cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 4 Middle East cell line development market by source, 2021 - 2033 (USD Million)
  • Table 5 Middle East cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 6 Middle East cell line development market by application, 2021 - 2033 (USD Million)
  • Table 7 Middle East cell line development market by country, 2021 - 2033 (USD Million)
  • Table 8 Oman cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 9 Oman cell line development market by source, 2021 - 2033 (USD Million)
  • Table 10 Oman cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 11 Oman cell line development market by application, 2021 - 2033 (USD Million)
  • Table 12 Oman cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 13 Saudi Arabia cell line development market by source, 2021 - 2033 (USD Million)
  • Table 14 Saudi Arabia cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 15 Saudi Arabia cell line development market by application, 2021 - 2033 (USD Million)
  • Table 16 UAE cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 17 UAE cell line development market by source, 2021 - 2033 (USD Million)
  • Table 18 UAE cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 19 UAE cell line development market by application, 2021 - 2033 (USD Million)
  • Table 20 Kuwait cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 21 Kuwait cell line development market by source, 2021 - 2033 (USD Million)
  • Table 22 Kuwait cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 23 Kuwait cell line development market by application, 2021 - 2033 (USD Million)
  • Table 24 Qatar cell line development market by product & services, 2021 - 2033 (USD Million)
  • Table 25 Qatar cell line development market by source, 2021 - 2033 (USD Million)
  • Table 26 Qatar cell line development market by type of cell line, 2021 - 2033 (USD Million)
  • Table 27 Qatar cell line development market by application, 2021 - 2033 (USD Million)
  • Table 28 Qatar cell line development market by product & services, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2024 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 Middle East cell line development market: Product & services outlook and key takeaways
  • Fig. 15 Middle East cell line development market: Product & services movement analysis
  • Fig. 16 Reagents and media market, 2021 - 2033 (USD Million)
  • Fig. 17 Equipment market, 2021 - 2033 (USD Million)
  • Fig. 18 Automated systems market, 2021 - 2033 (USD Million)
  • Fig. 19 Centrifuges market, 2021 - 2033 (USD Million)
  • Fig. 20 Bioreactors market, 2021 - 2033 (USD Million)
  • Fig. 21 Storage equipment market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Accessories and consumables market, 2021 - 2033 (USD Million)
  • Fig. 24 Services market, 2021 - 2033 (USD Million)
  • Fig. 25 Middle East cell line development market: Source outlook and key takeaways
  • Fig. 26 Middle East cell line development market: Source movement analysis
  • Fig. 27 Mammalian cell line market, 2021 - 2033 (USD Million)
  • Fig. 28 Non-Mammalian Cell Line Market, 2021 - 2033 (USD Million)
  • Fig. 29 Insects market, 2021 - 2033 (USD Million)
  • Fig. 30 Amphibians market, 2021 - 2033 (USD Million)
  • Fig. 31 Middle East cell line development market: Type of cell line outlook and key takeaways
  • Fig. 32 Middle East cell line development market: Type of cell line movement analysis
  • Fig. 33 Recombinant cell lines market, 2021 - 2033 (USD Million)
  • Fig. 34 Hybridomas market, 2021 - 2033 (USD Million)
  • Fig. 35 Continuous cell lines market, 2021 - 2033 (USD Million)
  • Fig. 36 Primary cell lines market, 2021 - 2033 (USD Million)
  • Fig. 37 Middle East cell line development market: Application outlook and key takeaways
  • Fig. 38 Middle East cell line development market: Application movement analysis
  • Fig. 39 Bioproduction market, 2021 - 2033 (USD Million)
  • Fig. 40 Drug discovery market, 2021 - 2033 (USD Million)
  • Fig. 41 Toxicity testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Tissue engineering market, 2021 - 2033 (USD Million)
  • Fig. 43 Others market, 2021 - 2033 (USD Million)
  • Fig. 44 Middle East cell line development market: Country outlook and key takeaways
  • Fig. 45 Saudi Arabia key country dynamics
  • Fig. 46 Saudi Arabia cell line development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 UAE key country dynamics
  • Fig. 48 UAE cell line development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Kuwait key country dynamics
  • Fig. 50 Kuwait cell line development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Oman key country dynamics
  • Fig. 52 Oman cell line development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Qatar key country dynamics
  • Fig. 54 Qatar cell line development market estimates and forecast, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!